Citius Oncology, Inc. (CTOR) stock
CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.52−0.03 (-5.87%)
Close on Nov 12, 2026Market cap $48.56MP/E –Yield –
Citius Oncology enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Citius Oncology's enterprise value was $48.53M on Nov 11, 2026, against $110.49M a year earlier. Over the last 4 years it ranged from $31.54M to $393.45M, with a median of $145.25M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $48.53M | -39.0% |
| 2025 | Dec 31, 2025 | $79.59M | +101.3% |
| 2024 | Dec 31, 2024 | $39.53M | -89.6% |
| 2023 | Dec 29, 2023 | $378.56M | +50.7% |
| 2022 | Dec 30, 2022 | $251.21M | – |
See a number that looks wrong?